Fall risk assessment for Parkinson's patients starting new medication
Part of Brain & nervous system clinical trials.
This study uses a wearable device to assess fall risk in people with Parkinson's disease who are about to start a new medication. The goal is to see if the device can help predict falls, which may improve safety and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You have been diagnosed with Parkinson's disease by a doctor.
- You are currently taking only levodopa and have motor fluctuations (times when symptoms change).
- Your doctor has planned to start you on a new medication called opicapone or safinamide.
- You do not have moderate to severe dementia, and you have not had brain surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses small wearable sensors to measure how you walk and move. The goal is to better track Parkinson's symptoms and predict falls, so your care can be more personalized.
This trial tests whether using wearable sensors can help doctors adjust Parkinson's medications more precisely to reduce motor fluctuations (times when symptoms worsen or improve unpredictably). It might help you have more stable symptom control throughout the day.
This study uses a smartphone app and a smartwatch to see if it can help predict the risk of developing Parkinson's disease. It is for people who have certain early signs that might be linked to Parkinson's, but who don't have the disease yet.
This study tests a fall prevention program designed for people with Parkinson's disease and their care partners. It aims to help reduce falls and improve balance and safety at home.
This study uses a smartphone app to track your symptoms and help predict how your medication affects you over time. It aims to improve treatment for people living with Parkinson's disease.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
Hear when a new Idiopathic Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.